WBL Featured on CCTV’s "Science and Innovation China" Program

In this era of rapid technological advancement, the "Science and Innovation China" program has become a key platform for showcasing scientific innovation and technological breakthroughs. Recently, WBL Company was selected for this program due to its outstanding contributions in the field of micro-energy medicine. This recognition not only highlights the company's efforts in scientific innovation but also aligns with China's third revolution in life sciences.

Academician Guo Yinglu Proposes the Concept of the Third Life Science Revolution

Throughout the history of life sciences, every major breakthrough has profoundly changed human understanding of life and treatment methods. From anatomy and physiology to molecular biology and precision medicine, each revolution has pushed human civilization forward. Under the leadership of Professor Guo Yinglu, an academician of the Chinese Academy of Engineering, the concept of "embracing the third life science revolution and focusing on the development of micro-energy medicine" has become a consensus within both academia and industry.

Micro-energy medicine is an emerging field that combines modern biological science and physics. Its core principle involves using low-intensity energy to act on human tissues, thereby regulating cellular functions. This non-invasive and precise treatment approach opens new possibilities for the prevention and treatment of various diseases.

Against this backdrop, WBL has focused on the research and industrialization of micro-energy medical technology, striving to transform cutting-edge technology into practical applications that benefit humanity. Behind these achievements is the guidance and support of Academician Guo Yinglu.

Academician Guo Yinglu: Key Driver of LIPUS Technology Development

As a pioneer in the field of urology in China, Academician Guo Yinglu has made significant contributions to clinical medicine while also closely following the development and transformation of cutting-edge technologies. His concept of "embracing the third life science revolution" has provided a clear direction for the development of micro-energy medicine.

Academician Guo played a crucial role in the development of LIPUS technology, a significant breakthrough in life sciences' third revolution. WBL’s LIPUS technology is one of the key projects driving this revolution.

WBL’s Innovation Journey Guided by Academician Guo Yinglu

WBL Medical Group has deeply implemented Academician Guo Yinglu’s idea of "integrated innovation" at multiple levels. Under his guidance and strong promotion, the development of LIPUS technology has involved long-term cross-national collaborative research with teams from the University of California, San Francisco (UCSF), led by Professors Fu Tai Lu and Gui Ting Lin, and Beijing University First Hospital's team led by Professor Zhongcheng Xin. After years of research, the optimal parameter combination for LIPUS treatment, including frequency, pulse intensity, and emission methods, was established, along with a complete theoretical mechanism and technological platform. Meanwhile, a multi-center, randomized controlled clinical study led by Professors Shuju Jie Xia and Zheng Li from Shanghai Jiaotong University’s First Affiliated Hospital validated the efficacy and safety of LIPUS in functional rehabilitation under different treatment frequencies, providing strong support for the standardization and guideline development of the technology.

It is within this academic framework that WBL, with its deep understanding of micro-energy medicine and technological innovation, successfully transformed LIPUS technology into an internationally competitive product. From the laboratory to clinical applications, this process embodies the dedication and wisdom of Academician Guo and his team.

WBL's Innovative Journey Under the Advocacy of Academician Guo Yinglu

As a company dedicated to micro-energy medical technology, WBL has always adhered to the philosophy of "technology changes life" and is committed to providing more efficient and safer solutions for human health. With years of technological accumulation and research investment, the company has obtained several core patents and achieved remarkable results in multiple clinical fields.

Being featured on the "Science and Innovation China" program is not only a recognition of WBL’s efforts in technological innovation but also a motivation for its future development. The company will seize this opportunity to strengthen its collaboration with academia and further promote continuous innovation and application of micro-energy medical technology.

Model A

Model B

Model C